HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
$1.81
Makalipas ang Oras ng Trabaho:(1.10%)+0.020
$1.83
Sarado: Set 12, 6:50:57 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.74
Sakop ng araw
$1.73 - $1.85
Sakop ng taon
$0.99 - $3.10
Market cap
144.32M USD
Average na Volume
619.31K
P/E ratio
31.83
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 15.66M | 16.21% |
Gastos sa pagpapatakbo | 8.62M | 33.69% |
Net na kita | 164.00K | 107.44% |
Net profit margin | 1.05 | 106.42% |
Kita sa bawat share | — | — |
EBITDA | 1.53M | 172.68% |
Aktuwal na % ng binabayarang buwis | 75.19% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 33.40M | -25.83% |
Kabuuang asset | 78.49M | -14.26% |
Kabuuang sagutin | 28.58M | -54.60% |
Kabuuang equity | 49.90M | — |
Natitirang share | 79.73M | — |
Presyo para makapag-book | 2.76 | — |
Return on assets | 3.85% | — |
Return on capital | 5.54% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 164.00K | 107.44% |
Cash mula sa mga operasyon | -5.23M | -44.96% |
Cash mula sa pag-invest | -438.00K | -143.33% |
Cash mula sa financing | 4.10M | — |
Net change in cash | -1.56M | 58.98% |
Malayang cash flow | -6.42M | -65.80% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
213
